Form 4: Plexus Director Sells 500 Shares Under 10b5-1 Plan

Plexus Corp. Director Karen Rapp sold 500 shares of common stock for $143.47 per share on November 28, 2025, as part of a pre-arranged Rule 10b5-1 trading plan.

Summary

• Karen Marie Rapp, a Director of Plexus Corp. (PLXS), reported the sale of 500 shares of common stock.
• The transaction occurred on November 28, 2025, at a price of $143.47 per share.
• The sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted on February 28, 2024.
• Following this transaction, Ms. Rapp directly beneficially owns 7,665 shares of Plexus Corp. common stock.

Sentiment

Score: 5

Explanation: A director's sale of shares, even under a 10b5-1 plan, is generally neutral to slightly negative as it reduces insider ownership. However, the pre-planned nature mitigates concerns about opportunistic selling.

Positives

• The sale was conducted under a pre-arranged Rule 10b5-1 plan, indicating a planned liquidity event rather than a reaction to recent company performance or market conditions.

Negatives

• A director selling shares, even under a 10b5-1 plan, reduces their direct ownership in the company.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• Shares were sold pursuant to a Rule 10b5-1 plan adopted on February 28, 2024.

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide information relevant to broader industry trends or competitive analysis.

Stakeholder Impact

• Shareholders: The sale by a director slightly reduces insider ownership, which some investors might view as a minor negative signal, though mitigated by the 10b5-1 plan.

Key Dates

Recommendation

This Form 4 filing reports a routine, pre-planned insider sale by a director. While it reduces insider ownership, the transaction was executed under a Rule 10b5-1 plan, suggesting it's for personal financial planning rather than a reflection of a negative outlook on the company. Such a transaction typically has minimal impact on the company's fundamental valuation or strategic direction, thus a 'hold' recommendation remains appropriate based solely on this filing.

Keywords

Plexus Corp, PLXS, Form 4, Insider Trading, Director Sale, Karen Rapp, 10b5-1 Plan, Equity Transaction